Search Results Page

Lupin back in the reckoning!

about 9 years ago

Yesterday, Lupin had hit a new 52-week low at Rs.920 and today it is up over Rs.18 higher from there at Rs.938 and this is after hitting an intra day high at Rs.950.

Lupin gets a shot in the arm

about 13 years ago

Shares of Lupin Limited are up 1.6% at Rs. 864 on NSE, post announcement from the company that it has successfully launched generic Zymaxid ophthalmic solution used in treating bacterial conjunctivitis in the US market, which has an annual size of approximately $ 62.3 million. Being the first to ...

Lupin on a new low

about 10 years ago

Lupin has been hitting new lows consistently since 23rd May. Today too, the new low was at Rs.1111.25

Lupin and Cipla bring cheer

about 6 years ago

Cipla and Lupin are having a fantastic day on the bourses today. The stock price of Cipla surged almost 6.5% to Rs.799.80

Lupin down in the red

about 11 years ago

After going up into the green yesterday on the back of its robust Q4FY16 performance, the stock price of Lupin has dipped into the red today morning. The stock is currently the top loser on the BSE, down 7% at Rs.1542.35, with an intra day at Rs.1525.35. The market has got over the numbers a ...

Lupin faces slew of "downgrades"

about 11 years ago

The woes of Lupin just got a bit worse. After the US FDA, it is the brokerage houses. Lupin went down intra day to Rs.1597.60, very close to its 52-week low of Rs.1589.40. Though recovered to Rs.1600 levels, the stock remains firmly in the red, down over 4%. CLSA put out a report, down ...

Lupin hits a new 52-week high

about 14 years ago

Lupin has hit a new 52-week high at Rs.638.65 and it continues to remain strongly in the green, up 1.38% at Rs.636.50. The stock has hit a new high after the company announced that its subsidiary Lupin Pharmaceuticals Inc. has received final approval for its Valsartan and Hydrochlorothiazide ...

Lupin at a new high

about 12 years ago

Lupin hit a new today at Rs.1442.30 and it continues to remain strongly in the positive and trades in the Rs.1436 range. There is unconfirmed news that Lupin in the final satges of negotiations with Merck Serono wherein Lupin will manufacture Merck’ $1.5 billion worth brande ...

Lupin falls after poor Q2

about 8 years ago

Lupin is down in the red today morning, going down over 3% to Rs.862.20. Its 52-week low is in the red at Rs.723.55.

Lupin down in the red

about 8 years ago

Lupin is down in the red today morning, going down over 3.5% to Rs.811; it has recovered from this low point but remains down at Rs.822 levels.

Lupin down in the red

about 8 years ago

Lupin is down in the red today. The stock has been losing for the last 2 days and has fallen -4.59% in the period.

Lupin swallows 'two' bitter pills

about 7 years ago

Lupin is currently the second top loser on the BSE. On the back of a poor show for Q2FY20, the company opened over 3% lower at Rs.748

Lupin in the limelight

about 8 years ago

Lupin was in the limelight in today’s trading session. The stock price rose over 2.5% to Rs.892. Ots 52-week high is at Rs.1090.

Lupin says "sayonara"

about 7 years ago

Lupin is in the news today, positive news and the stock price has reacted accordingly. From Monday’s close of Rs.735.95, the stock opened at Rs.749.20 and went to rise over 3% to hit an intraday high at Rs.759.15.

Lupin tumbles 3%

about 7 years ago

Lupin tumbled down today to Rs.742, slipping down almost 3%. It continues to trade around Rs.744 currently but the over all mood on the counter is not positive.

Lupin heaves sigh of relief

about 9 years ago

Lupin surely has reasons to celebrate. The company announced of Friday, after market hours that the US FDA completed Prior Approval Inspection (PAI) of its Goa manufacturing plant and it issued zero observations.

Lupin down in the red

about 8 years ago

And today, the stock price opened at a loss of 3% at Rs.864.30 and touched an intraday low of Rs.836, down 3.3%.

Lupin hit by FDA woes

about 7 years ago

The stock price has reacted negatively to this news. Falling today after 2 days of consecutive gains, the stock hit an intraday low at Rs.737.85

Lupin in great mood

about 7 years ago

From its close of Rs.547 on Friday, it opened today at Rs.564, going up to an intraday high at Rs.573.65 and it continues to remain in the positive.

Lupin rises and falls

about 6 years ago

The stock had closed yesterday at Rs.940.65, surged to Rs.954.35, which was so close to its 52-week high of Rs.955.85. It is now trading at Rs.941 levels

Lupin down in the red

about 5 years ago

The stock, which had closed on Friday at Rs.1230.35, went down over 4.5% to hit an intraday low at Rs.1173.35. Its 10% LC for the day is at Rs.1107.25.

Lupin rises and falls

about 8 years ago

The stock price reacted positively on opening, going up over 1.6% to Rs.866.25 but since then, the news has lost its fizz and the price is now in the red at Rs.850.45, down some 0.5%.

Lupin gets thumbs down

about 5 years ago

Currently the top loser on the BSE, the stock is down over 6% at Rs.986, slightly up from its intraday low at Rs.982. Its 10% LC for the day is at Rs.945.20.

Lupin has good news, stock falls!

about 8 years ago

This is actually good news but the market being in the mood that it is in currently, ignored this completely and the stock price is down in the red

Lupin in limelight

about 4 years ago

The stock opened weaker at Rs.607, the stock soon rose 1% to an intraday high at Rs.614.60 and is now just about holding on to the green at Rs.611, with volumes up 1.5 times.

Lupin jumps on getting USFDA nod

about 11 years ago

Lupin is up on the bourses today. From a closing of Rs.1829.45, it opened stronger at Rs.1845, going on to hit an intra day high of Rs.1895. It has come off this high and is now at Rs.1856, up over 1.5%. The stock is reacting positively to the news that it has received final approval for its ...

Lupin gets clean chit

about 9 years ago

The stock price surged over 7% to Rs.842.45 immediately after the news broke and is now at Rs.816 levels, up some 4%.

Lupin hits a new high

about 14 years ago

Lupin has hit a 52-week high today at Rs.661.60 and though it has come off from that high for now, it remains strongly in the green, up 2.26% at Rs.659.50. The stock is up on news that FIIs have hiked stake in the company from 27.99% at end Q3Fy13 to 28.8% at end of Q4FY13. The overseas hiki ...

Lupin hits new low

about 5 years ago

The stock is the top loser on the BSE since the opening bell. It opened lower at Rs.870 and went down to hit a new high at Rs.806.60

Lupin in limelight

about 5 years ago

The stock is currently the top gainer on the BSE, opening 1% higher at Rs.890 but soon rose to an intraday high at Rs.972.50, up 10%, on the back 8-times surge in volumes.

Lupin gets thumbs down

about 6 years ago

The market has clearly given the numbers a big thumbs down. It is currently the top loser on the BSE. It fell almost 2.5% to Rs.922.

Lupin at a new high

about 3 years ago

From its close of Rs.1440.30, the stock opened today at Rs.1449.75 and surged to hit a new 52-week high at Rs.1461.50. Profit booking came in at this level and the stock is now just about holding on to the green at Rs.1445.

Lupin hits high and slips

about 3 years ago

The stock is pretty volatile today; opening 2.5% higher at Rs.1429.95, which was a new 52-week high, the stock soon profit booking and slipped in the red; it is currently trading at 1396.

Lupin hits a new high

about 3 years ago

The stock, which had closed yesterday at Rs.873.80, opened slightly higher at Rs.875.05 and soon went on to hit a new 52-week high at Rs.889.90.

Lupin hits new high

about 14 years ago

Lupin hit a new 52-week high today at Rs.685.70 after having opened the day at Rs.677; since then the stock has seen profit taking and the stock is now barely holding up in the green, up 0.29% at Rs.675. The stock hit a high today after it reported that the US court of Appeals for the Federa ...

Lupin jumps as FII limit hiked

about 12 years ago

Lupin hit a new high today at Rs.1559.90 with volumes surging 1.5 times and it continues to trade around the same high levels. The stock hit a new high after the company informed the exchanges today afternoon that the Cabinet Committee on Economic Affair gave its approval to the proposal of t ...

Lupin bounces back

about 8 years ago

Despite the action initiated by the US FDA on Lupin’s Mandideep facility, Lupin, almost defiantly, remains in the green. The initial reaction was a drop

Lupin struck by "USFDA" virus!

about 11 years ago

Lupin is amongst the top losers on the bourses currently, going down intra day to a low of Rs.1`736.50. It continues to remain firmly in the red. The stock is down on news reports that the US FDA had inspected its Goa plant, which ended on 11th March. Post this, the FDA is stated to have give ...

Lupin hits a new high

about 3 years ago

The stock today opened almost 1% higher at Rs.823.15 and rose over 1.5% to hit a new 52-week high at Rs.830.30. Its currently trading at Rs.822 levels.

Lupin gets back on the "good" radar

about 10 years ago

Lupin opened pretty strong today morning at Rs.1700 level and going on to an intra day high at Rs.1710, up over 3%. Volumes too have surged over 1.5 times on the counter. The stock’s market cap rose to a jaw dropping Rs.75,388 crore. The stock is buzzing today, reacting to the new ...

Lupin gets a clean chit from USFDA

about 10 years ago

Lupin is amongst the top gainers on the BSE currently. The stock price rose over 8% intra day to Rs.1534.85 and is currently hovering at Rs.1503, up some 6%. Volumes have jumped up over two times. The stock is reacting to the news it announced on Saturday. The company informed that it has re ...

Lupin follows market

about 5 years ago

The stock opened lower at Rs.717 and went down 2% to an intraday low at Rs.705. Its 10% LC for the day is at Rs.647.60.

Pharma stocks get beaten down

about 12 years ago

The top four losers amongst the five on the BSE are all pharma stocks. This was the every same sector which was the toast of the street, even till yesterday but today, the tide has suddenly turned. The top loser is Torrent Pharma, down over 3%, Lupin is down 3%, Sun Pharma Advanced Research is do ...

Pharma gets "Trumped"

about 1 year ago

The Nifty Pharma Index fell 5-6% making it the worst-performing sector. Big losers included- Sun Pharma, Dr. Reddy’s, Cipla, Lupin fell between 5 to 8%.

Claris Life locked in UC

about 12 years ago

BSE-listed Claris Lifesciences’ shares are frozen in 20% upper circuit at Rs. 248.20 with current market cap standing at Rs. 1,584 crore. Total traded quantity of 7.36 lakh shares, in first hour of trade, are over 5 times the 2week average of 1.44 lakh shares on BSE. Big pharma firms su ...

Pharma stocks in the limelight

about 11 years ago

Pharma stocks seem to be in favor today morning. First it was Aurobindo Pharma hitting a new 52-week high at Rs.885. Suven Life Sciences rose over 5% to Rs.275.20. Then Lupin- it was not exactly as trailblazing like these two but it was up almost 1.5% at Rs.1865. Aurobindo hit a high after i ...

RANBAXY - TO BUY OR NOT TO BUY?

about 14 years ago

Well, the stock price is up over 3% currently, with more buyers than sellers on the counter. Does this mean that the market does not care about this ruling? It surely does but for the market, more than the felony charges or the loss of reputation, the fact that the company has already provided for the $500 million and this might have any material impact now is what matters. It was happy that the case which

THE BIG QUESTION - IS RANBAXY A GOOD BUY NOW?

about 13 years ago

This seems like an ongoing saga between Ranbaxy and the US FDA, with one facility after the other coming under the scanner. If one may recollect, it had begun last year when Ranbaxy had pleaded guilty , accepting the felony charges and it has also agreed to pay a criminal fine and forfeiture

GERUA IS THE COLOUR OF THE DAY!

about 9 years ago

Today, India and the Indian stock markets are coloured in a deep hue of saffron. The decisive victory of BJP in Karnataka, where the people gave a clear majority mandate to the BJP bodes well for the 2019 elections. The market is naturally thrilled to bits as the more BJP wins, the more it expects political stability and continuity in the economic policies too

Q4FY18 – A MIXED BAG OF SOUR AND SWEET

about 9 years ago

This week marks the beginning of the earning season for Q4FY18. Q2 and Q3 were pretty stable, what with the disruption of demon and GST earlier. And now we have Q4 where there is murmur of more weakness that strength in the numbers.

INDIA INC – STINGY WHEN IT COMES TO CSR

about 9 years ago

When Corporate Social Responsibility (CSR) was made mandatory, there was a big hue and cry. Why force companies to give? That was the moot question. But a recent finding put out by Bloomberg is even more telling, making us wonder whether we really know the companies that we are investing in. It also makes us wonder whether we should consider a company’s CSR as a criteria for investing.

BHAIYYA MERE RAKHI KE BANDHAN…..

about 9 years ago

You have Mothers day, Fathers day, Valentine’s day too. But India is unique in the sense that we are probably the only country which celebrates the beautiful bond shared by a brother and sister. Today, as we celebrate Rakshabandhan, we are actually bringing and keeping intact the family unit. Often given a very melodramatic twist in Indian movies, rakhi symbolizes the very special bond which a brother and sister share

WHEN US FDA MEETS INDIAN PHARMA COMPANIES...

about 9 years ago

This is the thought which comes to mind when we read this news today about Biocon also being pulled by the ‘villain’ of Indian pharma companies – the U.S. Food and Drug Administration (U.S. FDA). The stock was down today as its Bengaluru unit has received ten observations on Form 483 by the FDA. This ranges right from nonconformity to procedures and lack of trained and skilled employees

THE US FDA SCANNER - MORE GET UNDER

about 12 years ago

This is the thought which comes to mind when we read this news today about Ipca labs also being pulled by the 'villain' of Indian pharma companies - the U.S. Food and Drug Administration (U.S. FDA). The stock is the top loser today on news that the FDA has initiated action at the company's Indore SEZ plant and Ratlam API unit.

BLUE CHIP STOCKS - CHIPS OF THE PAST?

about 12 years ago

There was a time when a father bought shares like ACC, Grasim, TISCO, Tata Motors and the likes; portfolio was all Tata and Birla companies. But this basically comprised the 'blue chip' stocks which the father hoped to use as an investment to use when his child wants to get married

Export-oriented stocks in focus

about 9 months ago

Thus export-oriented stocks are clearly in focus and under pressure, reflecting caution ahead of the US Supreme Court ruling on Trump-era tariffs and the broader risk of renewed trade uncertainty.